Kunio Ohno

tella, Inc. engages in research and development of dendritic cell (DC) vaccine therapy. It operates through the following segments: Cell Medicine, Medical Support, and Pharmaceuticals. The Cell Medicine segment provides cancer treatment technology and know-hows centered on dendritic cell vaccine therapy. The Medical Support segment manages contact research organization (CRO) business and offers genetic testing services. The Pharmaceuticals segment deals with the development of dendritic cell vaccine as a cancer treatment. The company was founded by Yuichiro Yazaki on June 24, 2004 and is headquartered in Tokyo, Japan.

Business Continuity Systems, Inc. provides rental servers with high performance and comfortable access for a monthly fee of 600 yen. The private company is based in Yokohama, Japan. The rental servers come with 2GB of space, unlimited POP, unlimited transfer, free virus check, and are compatible with auto-responders, CGI, SSI, PHP, Ruby, MySQL, and SSL.

Asahi Kasei Kuraray Medical is dedicated to the advancement of technology in the fields of hemodialysis, therapeutic apheresis, transfusion therapy, and virus removal for biotherapeutic products. The company works to introduce therapies for intractable diseases by extending the frontiers of medical devices and systems, combining their core technology in functional materials for membrane filtration and selective absorption with pharmacology, chemistry, and mechanical engineering.